1 completed, 1 recruiting, 1 terminated. 3 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 1, Recruiting 1, Terminated 1 |
| Phase 2 | 3 | Completed 1, Recruiting 1, Terminated 1 |
Follow selicrelumab: new trials by email Literature Review of selicrelumab trials Research Report on selicrelumab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients With Metastatic Colorectal Cancer (Morpheus-CRC) Regorafenib, Atezolizumab, Imprime PGG - Colorectal Cancer | Phase 1 / Phase 2 | Terminated | Hoffmann-La Roche | 96 | 2018-09-27 | 2023-11-07 |
| A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer Capecitabine, Atezolizumab, Ipatasertib - Metastatic Breast Cancer | Phase 1 / Phase 2 | Recruiting | Hoffmann-La Roche | 1132 | 2018-03-30 | 2026-11-06 |
| A Study of Multiple Immunotherapy-Based Treatment Combinations in Participants With Metastatic Pancreatic Ductal Adenocarcinoma (Morpheus-Pancreatic Cancer) Nab-Paclitaxel, Gemcitabine, Oxaliplatin - Pancreatic Adenocarcinoma | Phase 1 / Phase 2 | Completed | Hoffmann-La Roche | 341 | 2017-07-05 | 2025-11-21 |
Breast Neoplasms (1) · Colorectal Neoplasms (1)
South Korea (3) · United States (3) · Australia (2) · France (2) · Germany (2) · Spain (2) · Israel (1) · Japan (1) · Switzerland (1) · Taiwan (1) · United Kingdom (1)
2017 (2), 2016 (1), 2023 (1)